AGL 40.22 Increased By ▲ 0.21 (0.52%)
AIRLINK 127.00 Decreased By ▼ -0.99 (-0.77%)
BOP 6.61 Increased By ▲ 0.01 (0.15%)
CNERGY 4.50 Decreased By ▼ -0.10 (-2.17%)
DCL 8.65 Increased By ▲ 0.17 (2%)
DFML 41.73 Increased By ▲ 0.25 (0.6%)
DGKC 87.15 Increased By ▲ 0.57 (0.66%)
FCCL 32.40 Increased By ▲ 0.26 (0.81%)
FFBL 65.40 Decreased By ▼ -0.02 (-0.03%)
FFL 10.22 Decreased By ▼ -0.03 (-0.29%)
HUBC 109.88 Decreased By ▼ -0.61 (-0.55%)
HUMNL 14.60 Decreased By ▼ -0.15 (-1.02%)
KEL 5.12 Decreased By ▼ -0.01 (-0.19%)
KOSM 7.72 Increased By ▲ 0.60 (8.43%)
MLCF 41.65 No Change ▼ 0.00 (0%)
NBP 59.60 Decreased By ▼ -0.49 (-0.82%)
OGDC 194.50 Decreased By ▼ -0.19 (-0.1%)
PAEL 28.27 Increased By ▲ 0.32 (1.14%)
PIBTL 7.87 Decreased By ▼ -0.13 (-1.63%)
PPL 152.34 Increased By ▲ 1.17 (0.77%)
PRL 26.60 Decreased By ▼ -0.28 (-1.04%)
PTC 16.05 Increased By ▲ 0.05 (0.31%)
SEARL 81.75 Increased By ▲ 3.55 (4.54%)
TELE 7.49 Increased By ▲ 0.10 (1.35%)
TOMCL 35.49 Decreased By ▼ -0.18 (-0.5%)
TPLP 8.25 Increased By ▲ 0.34 (4.3%)
TREET 16.18 Increased By ▲ 0.29 (1.83%)
TRG 52.73 Decreased By ▼ -0.03 (-0.06%)
UNITY 26.60 Increased By ▲ 0.05 (0.19%)
WTL 1.26 Decreased By ▼ -0.01 (-0.79%)
BR100 9,913 Decreased By -6.9 (-0.07%)
BR30 30,779 Increased By 27.7 (0.09%)
KSE100 93,468 Increased By 243.4 (0.26%)
KSE30 28,952 Increased By 67.1 (0.23%)

Bayern Munich's Dutch striker Arjen Robben has been ruled out of action for a month on Friday after picking up a groin injury in the Netherlands' 1-0 Euro 2016 qualifying loss to Iceland. Bayern club doctor Volker Braun revealed the player had suffered a serious muscular problem on Thursday night in Amsterdam which means he will be unavailable for the Bundesliga champions for four weeks.
Robben, 31, was substituted after half an hour during the defeat which has thrown the Dutch European qualifying campaign into turmoil. He will miss Sunday's make-or-break clash with Turkey with both teams hoping to salvage their hopes of making the European finals after woefully lacklustre campaigns.

Copyright Agence France-Presse, 2015

Comments

Comments are closed.